Browse by Countries

Request/Offer Detail

Title: Anti-CEACAM5 (Labetuzumab)-CL3-SN-38 ADC
TypeName: Business Offer
Request Date:2017/09/28
Country: United States
Summary: This ADC product is comprised of an anti-CEACAM5 monoclonal antibody conjugated via a CL3 linker to a SN-38. The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, SN-38 binds to DNA, causes DNA damage. http://www.creative-biolabs.com/adc/target-ceacam5-21.htm
Description:
Advantages:
Comments:
RequestId: 414
Name:Creative Biolabs
Telphone:
Email:marketing@creative-biolabs.com

Sponsors

smartportal sponsors